The following transactions have been completed by Corvus and its Management Team

Conduit Pharmaceuticals
Corvus is the founding and majority shareholder of Conduit Pharmaceuticals, a clinical stage specialty biopharmaceutical company led by highly experienced pharmaceutical executives, established to fund the development of successful, but de-prioritised, clinical assets licensed from large pharmaceutical companies to address areas of unmet medical need, through its exclusive relationships.